- Home
- OCGN vs GHI Comparison
OCGN vs GHI Comparison
Compare OCGN & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- GHI
- Stock Information
- Founded
- OCGN 2013
- GHI 1998
- Country
- OCGN United States
- GHI United States
- Employees
- OCGN N/A
- GHI N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- GHI Finance: Consumer Services
- Sector
- OCGN Health Care
- GHI Finance
- Exchange
- OCGN Nasdaq
- GHI Nasdaq
- Market Cap
- OCGN 278.3M
- GHI 269.5M
- IPO Year
- OCGN N/A
- GHI N/A
- Fundamental
- Price
- OCGN $1.03
- GHI $11.13
- Analyst Decision
- OCGN Strong Buy
- GHI Strong Buy
- Analyst Count
- OCGN 3
- GHI 4
- Target Price
- OCGN $6.00
- GHI $16.00
- AVG Volume (30 Days)
- OCGN 8.5M
- GHI 46.2K
- Earning Date
- OCGN 08-07-2025
- GHI 08-06-2025
- Dividend Yield
- OCGN N/A
- GHI 13.13%
- EPS Growth
- OCGN N/A
- GHI N/A
- EPS
- OCGN N/A
- GHI 0.45
- Revenue
- OCGN $4,522,000.00
- GHI $34,065,322.00
- Revenue This Year
- OCGN N/A
- GHI $228.92
- Revenue Next Year
- OCGN N/A
- GHI $4.27
- P/E Ratio
- OCGN N/A
- GHI $25.18
- Revenue Growth
- OCGN N/A
- GHI N/A
- 52 Week Low
- OCGN $0.52
- GHI $10.12
- 52 Week High
- OCGN $1.98
- GHI $15.27
- Technical
- Relative Strength Index (RSI)
- OCGN 55.00
- GHI 55.72
- Support Level
- OCGN $0.95
- GHI $11.93
- Resistance Level
- OCGN $1.15
- GHI $12.47
- Average True Range (ATR)
- OCGN 0.11
- GHI 0.31
- MACD
- OCGN -0.02
- GHI 0.02
- Stochastic Oscillator
- OCGN 22.62
- GHI 51.95
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.